Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
COVID-19 is a disease with unique characteristics that include lung thrombosis1, frequent diarrhoea2, abnormal activation of the inflammatory response3 and rapid deterioration of lung function consistent with alveolar oedema4. The pathological substrate for these findings remains unknown. Here we show that the lungs of patients with COVID-19 contain infected pneumocytes with abnormal morphology and frequent multinucleation. The generation of these syncytia results from activation of the SARS-CoV-2 spike protein at the cell plasma membrane level. On the basis of these observations, we performed two high-content microscopy-based screenings with more than 3,000 approved drugs to search for inhibitors of spike-driven syncytia. We converged on the identification of 83 drugs that inhibited spike-mediated cell fusion, several of which belonged to defined pharmacological classes. We focused our attention on effective drugs that also protected against virus replication and associated cytopathicity. One of the most effective molecules was the antihelminthic drug niclosamide, which markedly blunted calcium oscillations and membrane conductance in spike-expressing cells by suppressing the activity of TMEM16F (also known as anoctamin 6), a calcium-activated ion channel and scramblase that is responsible for exposure of phosphatidylserine on the cell surface. These findings suggest a potential mechanism for COVID-19 disease pathogenesis and support the repurposing of niclosamide for therapy. Lungs from patients who died from COVID-19 show atypical fused cells, the formation of which is mediated by the SARS-CoV-2 spike protein, and drugs that inhibit TMEM16F can prevent spike-induced syncytia formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
A Design Framework for Instrumenting Analytic Provenance for Problem-Solving Tasks
Yang, L., Morizet-Mahoudeaux, P., Guénand, A., & Mouloudi, A. (2018) · Advances in Intelligent Systems and Computing · doi:10.1007/978-981-10-8612-0_66 · Cited by 6,597
Ultrasensitive fluorescent proteins for imaging neuronal activity
Chen, T.-W., Wardill, T. J., Sun, Y., Pulver, S. R., Renninger, S. L., Baohan, A., Schreiter, E. R., Kerr, R. A., Orger, M. B., Jayaraman, V., et al. (2013) · Nature · doi:10.1038/nature12354 · Cited by 6,474
Thastrup, O., Cullen, P. J., Drøbak, B. K., Hanley, M. R., & Dawson, A. P. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2466 · Cited by 3,270
Clinical Characteristics of Covid-19 in New York City
Goyal, P., Choi, J. J., Pinheiro, L. C., Schenck, E. J., Chen, R., Jabri, A., Satlin, M. J., Campion, T. R., Nahid, M., Ringel, J. B., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2010419 · Cited by 2,234
Hoffmann, M., Kleine-Weber, H., & Pöhlmann, S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.04.022 · Cited by 1,852
Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G., & Decroly, E. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104742 · Cited by 1,679
Coagulation abnormalities and thrombosis in patients with COVID-19
Levi, M., Thachil, J., Iba, T., & Levy, J. H. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30145-9 · Cited by 1,544
Seow, J., Graham, C., Merrick, B., Acors, S., Pickering, S., Steel, K. J. A., Hemmings, O., O’Byrne, A., Kouphou, N., Galao, R. P., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00813-8 · Cited by 1,419
Self-citationTMEM16A confers receptor-activated calcium-dependent chloride conductance
Yang, Y. D., Cho, H., Koo, J. Y., Tak, M. H., Cho, Y., Shim, W.-S., Park, S. P., Lee, J., Lee, B., Kim, B.-M., et al. (2008) · Nature · doi:10.1038/nature07313 · Cited by 1,283
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Jose, R. J., & Manuel, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30216-2 · Cited by 1,240
Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02232-10 · Cited by 1,108
Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry
Simmons, G., Gosalia, D. N., Rennekamp, A. J., Reeves, J. D., Diamond, S. L., & Bates, P. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505577102 · Cited by 1,052
Calcium-dependent phospholipid scrambling by TMEM16F
Suzuki, J., Umeda, M., Sims, P. J., & Nagata, S. (2010) · Nature · doi:10.1038/nature09583 · Cited by 979
Kim, B. J., Nam, J. H., Kim, K. H., Joo, M., Ha, T. S., Weon, K. Y., Choi, S., Jun, J. Y., Park, E. J., Wie, J., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000366306 · Cited by 886
Matsuyama, S., Nagata, N., Shirato, K., Kawase, M., Takeda, M., & Taguchi, F. (2010) · Journal of Virology · doi:10.1128/jvi.01542-10 · Cited by 778
Millet, J. K., & Whittaker, G. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407087111 · Cited by 698
Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S., & Gallagher, T. (2011) · Journal of Virology · doi:10.1128/jvi.02062-10 · Cited by 693
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., Shum, D., & Kim, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00819-20 · Cited by 675
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs
Gabisonia, K., Prosdocimo, G., Aquaro, G. D., Carlucci, L., Zentilin, L., Secco, I., Ali, H., Braga, L., Gorgodze, N., Bernini, F., et al. (2019) · Nature · doi:10.1038/s41586-019-1191-6 · Cited by 478
Self-citationYang, H., Kim, A., David, T., Palmer, D., Jin, T., Tien, J., Huang, F., Cheng, T., Coughlin, S. R., Jan, Y. N., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.036 · Cited by 467
Edler, C., Schröder, A. S., Aepfelbacher, M., Fitzek, A., Heinemann, A., Heinrich, F., Klein, A., Langenwalder, F., Lütgehetmann, M., Meißner, K., et al. (2020) · International Journal of Legal Medicine · doi:10.1007/s00414-020-02317-w · Cited by 425
Carter, M. J., Fish, M., Jennings, A., Doores, K. J., Wellman, P., Seow, J., Acors, S., Graham, C., Timms, E., Kenny, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1054-6 · Cited by 419
Self-citationCoronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner
Burkard, C., Verheije, M. H., Wicht, O., van Kasteren, S. I., van Kuppeveld, F. J., Haagmans, B. L., Pelkmans, L., Rottier, P. J. M., Bosch, B. J., & de Haan, C. A. M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004502 · Cited by 388
Bussani, R., Schneider, E., Zentilin, L., Collesi, C., Ali, H., Braga, L., Volpe, M. C., Colliva, A., Zanconati, F., Berlot, G., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103104 · Cited by 358
Self-citationThe biology and toxicology of molluscicides, bayluscide
Andrews, P., Thyssen, J., & Lorke, D. (1982) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(82)90064-x · Cited by 347
Molecular mediators of macrophage fusion
Helming, L., & Gordon, S. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.07.005 · Cited by 326
van den Eijnde, S. M., van den Hoff, M. J. B., Reutelingsperger, C. P. M., van Heerde, W. L., Henfling, M. E. R., Vermeij-Keers, C., Schutte, B., Borgers, M., & Ramaekers, F. C. S. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.20.3631 · Cited by 289
Intracellular calcium-release channels: regulators of cell life and death
Marks, A. R. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.272.2.h597 · Cited by 234
Jin, X., Shah, S., Liu, Y., Zhang, H., Lees, M., Fu, Z., Lippiat, J. D., Beech, D. J., Sivaprasadarao, A., Baldwin, S. A., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004184 · Cited by 187
Kappagoda, S., Singh, U., & Blackburn, B. G. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0203 · Cited by 166
Calmodulin‐dependent activation of the epithelial calcium‐dependent chloride channel TMEM16A
Tian, Y., Kongsuphol, P., Hug, M., Ousingsawat, J., Witzgall, R., Schreiber, R., & Kunzelmann, K. (2011) · The FASEB Journal · doi:10.1096/fj.10-166884 · Cited by 144
Miner, K. T., Labitzke, K., Liu, B., Wang, P., Henckels, K., Gaida, K., Elliott, R., Chen, J. J., Liu, L., Leith, A., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00051 · Cited by 127
Endogenous calcium channels in human embryonic kidney (HEK293) cells
Berjukow, S., Döring, F., Froschmayr, M., Grabner, M., Glossmann, H. H., & Hering, S. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15463.x · Cited by 121
Bill, A., Gutierrez, A., Kulkarni, S., Kemp, C., Bonenfant, D., Voshol, H., Duvvuri, U., & Gaither, L. A. (2015) · Oncotarget · doi:10.18632/oncotarget.3277 · Cited by 118
TMEM16F phospholipid scramblase mediates trophoblast fusion and placental development
Zhang, Y., Le, T., Grabau, R. P., Mohseni, Z. S., Kim, H., Natale, D. R. C., Feng, L., Pan, H., & Yang, H. (2020) · Science Advances · doi:10.1126/sciadv.aba0310 · Cited by 118
Burock, S., Daum, S., Keilholz, U., Neumann, K., Walther, W., & Stein, U. (2018) · BMC Cancer · doi:10.1186/s12885-018-4197-9 · Cited by 117
Differential effects of anoctamins on intracellular calcium signals
Cabrita, I., Benedetto, R. D., Fonseca, A. F., Wanitchakool, P., Sirianant, L., Skryabin, B. V., Sievers, L. K., Pavenstädt, H. J., Schreiber, R., & Kunzelmann, K. (2017) · The FASEB Journal · doi:10.1096/fj.201600797rr · Cited by 112
Modulation of phosphatidylserine epitope expression by BeWo cells during forskolin treatment
LYDEN, T. W., Ah-Kau, N. G., & Rote, N. S. (1993) · Placenta · doi:10.1016/s0143-4004(05)80259-0 · Cited by 111
Cell-surface phosphatidylserine regulates osteoclast precursor fusion
Verma, S. K., Leikina, E., Melikov, K., Gebert, C. M., Kram, V., Young, M. F., Uygur, B., & Chernomordik, L. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.809681 · Cited by 108
Ma, M., Gao, M., Guo, K.-M., Wang, M., Li, X., Zeng, X., Sun, L., Lv, X., Du, Y., Wang, G., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08874 · Cited by 103
Rival, C. M., Xu, W., Shankman, L. S., Morioka, S., Arandjelovic, S., Lee, C. S., Wheeler, K. M., Smith, R. P., Haney, L. B., Isakson, B. E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12406-z · Cited by 100
Priming Time: How Cellular Proteases Arm Coronavirus Spike Proteins
Hoffmann, M., Hofmann-Winkler, H., & Pöhlmann, S. (2018) · Activation of Viruses by Host Proteases · doi:10.1007/978-3-319-75474-1_4 · Cited by 95
Anoctamin 5/TMEM16E facilitates muscle precursor cell fusion
Whitlock, J. M., Yu, K., Cui, Y., & Hartzell, H. C. (2018) · The Journal of General Physiology · doi:10.1085/jgp.201812097 · Cited by 79
Regulation of STIM1/Orai1-dependent Ca2+ signalling in platelets
Münzer, P., Gawaz, M., Borst, O., & Lang, F. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-02-0176 · Cited by 74
Block by fluoxetine of volume‐regulated anion channels
Maertens, C., Wei, L., Voets, T., Droogmans, G., & Nilius, B. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702314 · Cited by 72
Cited by
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion
Mlcochova, P., Kemp, S. A., Dhar, M. S., Papa, G., Meng, B., Ferreira, I. A. T. M., Datir, R., Collier, D. A., Albecka, A., Singh, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03944-y · Cited by 1,337
Self-citationSARS-CoV-2 Omicron spike mediated immune escape and tropism shift
Meng, B., Ferreira, I. A. T. M., Abdullahi, A., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerba, P. P., Fatihi, S., Rathore, S., et al. (2021) · doi:10.1101/2021.12.17.473248 · Cited by 1,147
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Meng, B., Abdullahi, A., Ferreira, I. A. T. M., Goonawardane, N., Saito, A., Kimura, I., Yamasoba, D., Gerber, P. P., Fatihi, S., Rathore, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04474-x · Cited by 1,146
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Willett, B. J., Grove, J., MacLean, O. A., Wilkie, C., De Lorenzo, G., Furnon, W., Cantoni, D., Scott, S., Logan, N., Ashraf, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01143-7 · Cited by 785
Therapeutic strategies for COVID-19: progress and lessons learned
Li, G., Hilgenfeld, R., Whitley, R., & De Clercq, E. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00672-y · Cited by 676
Metadata
- Authors
- Braga, L., Ali, H., Secco, I., Chiavacci, E., Neves, G., Goldhill, D., Penn, R., Jimenez-Guardeño, J. M., Ortega-Prieto, A. M., Bussani, R., Cannatà, A., Rizzari, G., Collesi, C., Schneider, E., Arosio, D., Shah, A. M., Barclay, W. S., Malim, M. H., Burrone, J., & Giacca, M.
- Venue
- Nature
- Published
- 2021-04-07
- Volume
- 594
- Issue
- 7861
- Pages
- 88-93
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W3152312420
- Cited by
- 403
- References
- 46
- FWCI
- 25.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.